Sofinnova Ventures »

Achieve Life Sciences shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Achieve Life Sciences (ACHV) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Achieve Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Achieve Life Sciences held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achieve Life Sciences by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.9M 1.5M 4.55

More positions owned by Sofinnova Ventures

Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Aerovate Therapeutics (AVTE)
Merck & Co (MRK)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Novo-Nordisk A S Adr (NVO)
Incyte Corporation (INCY)
Argenx SE Sponsored Adr (ARGX)
Intuitive Surgical (ISRG)
Dyne Therapeutics (DYN)
Inhibrx (INBX)
Elanco Animal Health (ELAN)
IDEXX Laboratories (IDXX)
AstraZeneca Sponsored Adr (AZN)

View all positions for Sofinnova Ventures

Top funds holding Achieve Life Sciences

Franklin Resources
Propel Bio Management
Sofinnova Ventures
Vanguard Group
ADAR1 Capital Management
Altium Capital Management
Nantahala Capital Management
CVI Holdings
Alyeska Investment Group
Shay Capital
Long Focus Capital Management
Susquehanna International
Simplify Asset Management
Geode Capital Management
Millennium Management

View all funds holding Achieve Life Sciences